TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.

Jessica A Pollard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.